PPD becomes first CRO partner for MIT's initiative
Through a business unit formed following its 2016 acquisition of Evidera, Wilmington-based contract research organization Pharmaceutical Product Development has become the first partner of its kind for a Massachusetts Institute of Technology drug development initiative.
PPD and Evidera, the CRO’s real-world research and market access business unit, have joined MIT's Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS) initiative.
“As the first CRO to join NEWDIGS, we…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Jennifer Henderson Source Type: news